During the past decade, Staffordshire General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Staffordshire General Hospital" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials, followed by "Lymphoma Trials Office" with 3 trials sponsored, "Institute of Cancer Research, United Kingdom" with 2 trials sponsored, "University of Leeds" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Staffordshire General Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "Lymphoma Trials Office" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator and "Nordic Lymphoma Group" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Staffordshire General Hospital" are "Lymphoma" (9 trials), "Fallopian Tube Cancer" (4 trials), "Ovarian Cancer" (4 trials), "Primary Peritoneal Cavity Cancer" (4 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Staffordshire General Hospital" in a lesser frequency.

Most popular intervention types in "Staffordshire General Hospital" are "Drug" (23 trials), "Procedure" (9 trials), "Biological" (8 trials), "Other" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (5 trials), "etoposide" (5 trials), "vincristine sulfate" (5 trials) and "chlorambucil" (4 trials). Other intervention names were less common.

The vast majority of trials in "Staffordshire General Hospital" are 19 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Staffordshire General Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Staffordshire General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Staffordshire General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".